These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 11850822
21. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ. Prostate; 2008 Jan 01; 68(1):42-9. PubMed ID: 18004747 [Abstract] [Full Text] [Related]
22. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M. Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910 [Abstract] [Full Text] [Related]
23. The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma. Chu DC, Chuang CK, Fu JB, Huang HS, Tseng CP, Sun CF. J Urol; 2002 Apr 01; 167(4):1854-8. PubMed ID: 11912447 [Abstract] [Full Text] [Related]
24. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age? Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A. Eur J Med Res; 2004 Nov 29; 9(11):523-7. PubMed ID: 15649863 [Abstract] [Full Text] [Related]
25. DNA methyltransferase levels and altered CpG methylation in the total genome and in the GSTP1 gene in human glioma cells transfected with sense and antisense DNA methyltransferase cDNA. Antoun G, Baylin SB, Ali-Osman F. J Cell Biochem; 2000 Apr 29; 77(3):372-81. PubMed ID: 10760946 [Abstract] [Full Text] [Related]
26. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, Asgari K, Freije D, van Rees B, Gage WR, Bova GS, Isaacs WB, Brooks JD, DeWeese TL, De Marzo AM, Nelson WG. Am J Pathol; 2001 Nov 29; 159(5):1815-26. PubMed ID: 11696442 [Abstract] [Full Text] [Related]
27. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y. Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420 [Abstract] [Full Text] [Related]
28. DNA methylation and gene silencing in cancer: which is the guilty party? Clark SJ, Melki J. Oncogene; 2002 Aug 12; 21(35):5380-7. PubMed ID: 12154400 [Abstract] [Full Text] [Related]
29. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N. Cancer Res; 1998 Dec 01; 58(23):5310-4. PubMed ID: 9850055 [Abstract] [Full Text] [Related]
30. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Melki JR, Vincent PC, Clark SJ. Cancer Res; 1999 Aug 01; 59(15):3730-40. PubMed ID: 10446989 [Abstract] [Full Text] [Related]
31. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Sasaki M, Kaneuchi M, Sakuragi N, Dahiya R. Cancer Res; 2003 Jun 15; 63(12):3101-6. PubMed ID: 12810635 [Abstract] [Full Text] [Related]
32. Methylation of the CD44 metastasis suppressor gene in human prostate cancer. Lou W, Krill D, Dhir R, Becich MJ, Dong JT, Frierson HF, Isaacs WB, Isaacs JT, Gao AC. Cancer Res; 1999 May 15; 59(10):2329-31. PubMed ID: 10344738 [Abstract] [Full Text] [Related]
33. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas. Kim J, Lee HS, Bae SI, Lee YM, Kim WH. Anticancer Res; 2005 May 15; 25(6B):4013-9. PubMed ID: 16309193 [Abstract] [Full Text] [Related]
34. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Lee WH, Isaacs WB, Bova GS, Nelson WG. Cancer Epidemiol Biomarkers Prev; 1997 Jun 15; 6(6):443-50. PubMed ID: 9184779 [Abstract] [Full Text] [Related]
35. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer. Suh CI, Shanafelt T, May DJ, Shroyer KR, Bobak JB, Crawford ED, Miller GJ, Markham N, Glode LM. Mol Cell Probes; 2000 Aug 15; 14(4):211-7. PubMed ID: 10970725 [Abstract] [Full Text] [Related]
36. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy. Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Müller SC, von Rücker A. Eur Urol; 2007 Mar 15; 51(3):665-74; discussion 674. PubMed ID: 16956712 [Abstract] [Full Text] [Related]
37. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ. Hum Mol Genet; 2009 Aug 15; 18(16):3098-109. PubMed ID: 19477956 [Abstract] [Full Text] [Related]
38. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. Kang GH, Lee S, Lee HJ, Hwang KS. J Pathol; 2004 Feb 15; 202(2):233-40. PubMed ID: 14743506 [Abstract] [Full Text] [Related]
39. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma. Chuang CK, Chu DC, Tzou RD, Liou SI, Chia JH, Sun CF. Cancer Detect Prev; 2007 Feb 15; 31(1):59-63. PubMed ID: 17291695 [Abstract] [Full Text] [Related]
40. Gene promoter methylation in prostate tumor-associated stromal cells. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG. J Natl Cancer Inst; 2006 Feb 15; 98(4):255-61. PubMed ID: 16478744 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]